Short Communication: Coronavirus Disease 19 Among People Living with HIV in Western India: An Observational Cohort Study
- Sanjay Pujari 1
- Sunil Gaikwad 1
- Abhishek Chitalikar 2
- Digamber Dabhade 2
- Kedar Joshi 2
- Vivek Bele 2
- 1 - Department of HIV Medicine and Infectious Diseases - Poona Hospital and Research Center - Pune India
- 2 - Institute of Infectious Diseases - Pune India
May 11, 2022
Abstract
A retrospective cohort study was conducted to assess clinical characteristics and outcomes of coronavirus disease-19 (COVID-19) among people living with HIV (PLHIV) in western India. Out of 86 PLHIV with COVID-19 illness, 19.7% had severe/critical illness and 6 (6.9%) individuals died. Median (interquartile range) age was 51 (47–56) years and 77.6% were male. Eighty-five PLHIV were on antiretroviral treatment with 98% having a viral load <200 copies/mL. Hypertension (HTN) (38.3%) and diabetes mellitus (17.4%) were commonest comorbidities. Fifty-eight percent PLHIV were hospitalized while 6.9% individuals needed intensive care. Presence of medical comorbidity was significantly associated with severe/critical COVID-19, whereas HTN was significantly associated with mortality. Recovery from COVID-19 was documented in 93% PLHIV. In conclusion, PLHIV in western India have similar COVID-19 clinical outcomes as compared with those reported historically among general population. Presence of medical comorbidities rather than HIV-related disease characteristics is associated with severe COVID-19 illness.
Comments
Be the first to comment on this protocol.